Latest news with #ATI
Yahoo
2 days ago
- Business
- Yahoo
Wall Street Analysts See Allegheny Technologies (ATI) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Allegheny Technologies (ATI). Allegheny Technologies currently has an average brokerage recommendation (ABR) of 1.36, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 11 brokerage firms. An ABR of 1.36 approximates between Strong Buy and Buy. Of the 11 recommendations that derive the current ABR, nine are Strong Buy, representing 81.8% of all recommendations. Check price target & stock forecast for Allegheny Technologies here>>>While the ABR calls for buying Allegheny Technologies, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential. Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation. This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements. Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision. In spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures. The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5. It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them. In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research. Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns. Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements. In terms of earnings estimate revisions for Allegheny Technologies, the Zacks Consensus Estimate for the current year has increased 1.3% over the past month to $3.01. Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Allegheny Technologies. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Therefore, the Buy-equivalent ABR for Allegheny Technologies may serve as a useful guide for investors. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ATI Inc. (ATI) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29-05-2025
- Business
- Yahoo
Titanium Alloy Industry Report 2025: Asia Pacific Emerges as Key Player - Global Market Analysis, Size, Share, Growth, Trends, and Forecasts to 2032
The global titanium alloy market set to grow from US$ 5.4 Bn in 2025 to US$ 8.6 Bn by 2032, with a CAGR of 6.8%. Demand is rising in aerospace, automotive, and medical sectors, driven by lightweight, high-performance applications. Key players include VSMPO-AVISMA and ATI, with Asia Pacific emerging as a growth hub. Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "Titanium Alloy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Alloy Type, End-user, Geographic Coverage and By Company)" has been added to offering. The global titanium alloy market is on an upward trajectory, projected to grow from US$ 5.4 billion in 2025 to US$ 8.6 billion by 2032, reflecting a robust CAGR of 6.8% during the forecast period. This expansion is driven by increasing demand across aerospace, automotive, and medical industries, with the market expected to expand 1.6x by 2032 compared to its 2025 levels. Market Insights Titanium alloys are renowned for their exceptional attributes, making them indispensable in high-performance sectors like aerospace, defense, automotive, and medical engineering. Specifically, Alpha + Beta titanium alloys dominate usage across these sectors due to their high-temperature and high-strength performance. The aerospace and military industries are the primary consumers, benefiting from these alloys' unique material advantages for aircraft structures and defense equipment. The United States remains a market leader, with advanced aerospace capabilities, while rapid industrialization in China and the Asia Pacific fuels regional growth. Market Drivers The automotive sector's push for lightweight, high-performance materials is a significant growth driver. As the sector moves towards electric vehicles (EVs) and stringent emissions regulations, the demand for titanium alloys accelerates. These alloys help reduce vehicle weight, improve fuel efficiency, and lower emissions. Premium manufacturers like BMW and Ferrari incorporate titanium components, and EV producers explore titanium's potential, as evidenced by partnerships like Toyota's with Osaka Titanium Technologies and Ford's patented titanium-based engine components. Key Business Opportunities The medical sector offers substantial opportunities, with titanium alloys widely used in implants due to their biocompatibility and durability. With aging populations and rising chronic diseases, demand for durable implants, especially in orthopedic, dental, and cardiovascular applications, is increasing. Technological advancements like 3D printing enhance implant customization, with companies like Stryker Corporation expanding titanium-based product lines for personalized healthcare. Furthermore, the trend toward titanium recycling presents opportunities for sustainability, with processes saving up to 95% of the energy required for new production. Collaborations like IperionX with Aperam illustrate the potential for converting titanium scrap into high-performance products, supporting sustainable practices in manufacturing. Regional Analysis North America continues to lead the titanium alloy market, particularly in aerospace, driven by major players and robust military investments. Europe observes steady growth, integrating titanium in automotive and medical sectors. Meanwhile, Asia Pacific, led by China, emerges as a hotspot for aerospace and automotive applications, contributing significantly to global market expansion. Competitive Landscape Leading companies such as VSMPO-AVISMA, ATI, TIMET, NIPPON STEEL CORPORATION, and KOBE STEEL, LTD. dominate the competitive landscape through strategic expansions and technological innovations. These advancements, including AI and 3D printing, optimize production and develop complex titanium components. Companies Featured Allegheny Technologies Incorporated (ATI) Baoji Titanium Co. Ltd. Western Superconducting Technologies Co, Ltd. (WST) Kobe Steel, Ltd. Western Metal Materials Co. Ltd. (WMM) Precision Castparts Corp. (PCC) UKTMP JSC Toho Titanium Co., Ltd. Hermith GmbH Howmet Aerospace Inc. Mishra Dhatu Nigam Limited (MIDHANI) ERAMET Group Xinjiang Xiangsheng New Material Technology Co., Ltd. Oric Italiana S.r.l. L.C.M.A. S.A. ZTMC Ltd. Segmentation Alloy Type: Alpha & Near-Alpha Titanium Alloy Alpha + Beta Titanium Alloy Beta & Near-Beta Titanium Alloy End-user: Aerospace Military Chemical Power Generation Automotive & Marine Medical Implants Consumer Goods Sporting Goods & Equipment Others (Jewelry, Construction) Region: North America Europe Asia Pacific Latin America Middle East & Africa For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Axios
28-05-2025
- Automotive
- Axios
Army weapons shake-up backed by Hegseth and other Trump picks
Defense Secretary Pete Hegseth and the wider Trump White House are providing "air cover" for the U.S. Army's ongoing vehicle-and-weapons upheaval, the service's top civilian told Axios. Why it matters: System shocks are exactly that — a shock. Executing them requires support, especially at such a politically volatile moment. "Fundamentally, they just have a risk tolerance that doesn't match, I think, previous administrations," Secretary Dan Driscoll said at a live Axios event. "There are a lot of states and congressional districts and lobbyists; there are rational reasons why it exists the way it is today," he said. "Those reasons are just not in the best interest of soldiers." Friction point: On the materiel chopping block are longtime favorites (Humvee, Apache and the Improved Turbine Engine Program) as well as relative newcomers (M10 Booker). By the numbers: The Army is expected to save $48 billion over the next five years. Driscoll told Axios he and others consider comparisons between the Army Transformation Initiative (ATI) and Elon Musk's DOGE a compliment. "I think DOGE is loaded," he added. "You have a lot of people who have these feelings about it." The intrigue: Both Driscoll and Army Chief of Staff Gen. Randy George have been working the media circuit since ATI was announced May 1.
Hamilton Spectator
28-05-2025
- Business
- Hamilton Spectator
Aja Health and Wellness Inc. Announces Launch of Nasal Product for Migraine Headache Relief and Provides Update on Delay in Filing Financial Statements
Not for dissemination in the United States of America VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) — Aja Health and Wellness Inc. ('Aja' or the 'Company') (TSXV:Aja) announces that its wholly owned subsidiary Aja Therapeutics Inc. ('ATI') is launching a nasal spray product for migraine headache relief. ATI's research and development lab in Atlanta, Georgia has concluded initial testing of the nasal spray and anticipates the product will be released for retail sale in the United States on May 28, 2025. The nasal spray will be available for purchase by United States residents at . 'There are a reported 32 million migraine sufferers in the United States who are looking for an alternative to harsh chemicals for migraine prevention and treatment. ATI's proprietary flavonoid extract and nasal spray application quickly targets pain centers offering fast relief without side effects or risk of long-term damage,' commented Jim Viccars, co-founder and Vice President of ATI. 'With Canada and the United Kingdom reporting 16 million people with migraine issues, this product has global market opportunity,' added Mr. Viccars. Update on Delay in Filing Annual Financial Statements Aja also announces that it is getting closer to filing its annual audited financial statements for the financial year ending December 31, 2024, including the related management's discussion and analysis and certifications from the CEO and CFO (the 'Required Annual Filings'). On May 6, 2025, the Alberta Securities Commission issued a management cease trade order (the 'MCTO') because the Company was unable to file the Required Annual Filings in time to meet the April 30, 2025 filing deadline. Aja previously announced that the delay in filing the Required Annual Filings was due to the auditors of the Company seeking guidance from the auditor's technical committee with respect to the characterization of the previously announced reverse takeover transaction, which closed on September 17, 2024 (the 'RTO'). After consulting with the auditor's technical committee, the auditors determined that the RTO will be characterized as a series of acquisitions for accounting purposes. In connection with the RTO, the auditors require a valuation of the purchase price allocation to complete the audited financial statements for the financial year ending December 31, 2024. The Company is in the process of retaining a valuator to complete the valuation. The Company expects to have a valuator engaged on or before June 2, 2025 and anticipates the valuation will be completed on or before July 4, 2025. The Company expects to file the Required Annual Filings on or before July 31, 2025. While the MCTO restricts all trading in securities of the Company by executive officers of the Company until the MCTO is no longer in effect, regular trading by current and future investors outside the Company continues as normal. The MCTO will be in effect until two full business days after the Required Annual Filings are filed. Until the Required Annual Filings are filed, the Company intends to satisfy the provisions of the Alternative Information Guidelines set out in National Policy 12-203 - Management Cease Trade Orders . Update on Filing of Interim Financial Statements As a result of the delay in filing the Required Annual Filings, Aja also announces that it anticipates being unable to file its unaudited interim financial statements for the three months ended March 31, 2025, the management's discussion and analysis for the same period and management certifications of the interim filings (the 'Interim Filings') by the filing deadline of May 30, 2025. Aja is working to complete the Interim Filings as soon as possible and expects the Interim Filings to be filed concurrently with the filing of the Required Annual Filings. On behalf of the Board of Directors 'Sanjeev Parsad' Sanjeev Parsad President, CEO and Director The above may contain 'forward-looking information' within the meaning of applicable securities laws. When used in this address, the words 'estimate', 'project', 'belief', 'anticipate', 'intend', 'expect', 'plan', 'predict', 'may' or 'should' and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although the Company believes in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, readers are cautioned to not place undue reliance on forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date of publication of this information and the Company undertakes no obligation to update such forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Furthermore, the Company undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Company. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. For further information, contact: Sanjeev Parsad, President and CEO Phone: (604) 678.9115 Fax: (604) 678.9279 E-mail: sparsad@ Web:
Yahoo
27-05-2025
- Business
- Yahoo
Aja Health and Wellness Inc. Announces Launch of Nasal Product for Migraine Headache Relief and Provides Update on Delay in Filing Financial Statements
VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that its wholly owned subsidiary Aja Therapeutics Inc. ("ATI") is launching a nasal spray product for migraine headache relief. ATI's research and development lab in Atlanta, Georgia has concluded initial testing of the nasal spray and anticipates the product will be released for retail sale in the United States on May 28, 2025. The nasal spray will be available for purchase by United States residents at "There are a reported 32 million migraine sufferers in the United States who are looking for an alternative to harsh chemicals for migraine prevention and treatment. ATI's proprietary flavonoid extract and nasal spray application quickly targets pain centers offering fast relief without side effects or risk of long-term damage," commented Jim Viccars, co-founder and Vice President of ATI. "With Canada and the United Kingdom reporting 16 million people with migraine issues, this product has global market opportunity," added Mr. Viccars. Update on Delay in Filing Annual Financial Statements Aja also announces that it is getting closer to filing its annual audited financial statements for the financial year ending December 31, 2024, including the related management's discussion and analysis and certifications from the CEO and CFO (the "Required Annual Filings"). On May 6, 2025, the Alberta Securities Commission issued a management cease trade order (the "MCTO") because the Company was unable to file the Required Annual Filings in time to meet the April 30, 2025 filing deadline. Aja previously announced that the delay in filing the Required Annual Filings was due to the auditors of the Company seeking guidance from the auditor's technical committee with respect to the characterization of the previously announced reverse takeover transaction, which closed on September 17, 2024 (the "RTO"). After consulting with the auditor's technical committee, the auditors determined that the RTO will be characterized as a series of acquisitions for accounting purposes. In connection with the RTO, the auditors require a valuation of the purchase price allocation to complete the audited financial statements for the financial year ending December 31, 2024. The Company is in the process of retaining a valuator to complete the valuation. The Company expects to have a valuator engaged on or before June 2, 2025 and anticipates the valuation will be completed on or before July 4, 2025. The Company expects to file the Required Annual Filings on or before July 31, 2025. While the MCTO restricts all trading in securities of the Company by executive officers of the Company until the MCTO is no longer in effect, regular trading by current and future investors outside the Company continues as normal. The MCTO will be in effect until two full business days after the Required Annual Filings are filed. Until the Required Annual Filings are filed, the Company intends to satisfy the provisions of the Alternative Information Guidelines set out in National Policy 12-203 - Management Cease Trade Orders. Update on Filing of Interim Financial Statements As a result of the delay in filing the Required Annual Filings, Aja also announces that it anticipates being unable to file its unaudited interim financial statements for the three months ended March 31, 2025, the management's discussion and analysis for the same period and management certifications of the interim filings (the "Interim Filings") by the filing deadline of May 30, 2025. Aja is working to complete the Interim Filings as soon as possible and expects the Interim Filings to be filed concurrently with the filing of the Required Annual Filings. On behalf of the Board of Directors "Sanjeev Parsad" Sanjeev ParsadPresident, CEO and Director The above may contain "forward-looking information" within the meaning of applicable securities laws. When used in this address, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although the Company believes in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, readers are cautioned to not place undue reliance on forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date of publication of this information and the Company undertakes no obligation to update such forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Furthermore, the Company undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Company. All forward-looking statements contained in this news release are expressly qualified by this cautionary further information, contact: Sanjeev Parsad, President and CEOPhone: (604) 678.9115Fax: (604) 678.9279E-mail: sparsad@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
